Literature DB >> 12637374

Tobacco, coffee, and Parkinson's disease.

Catharine Gale, Christopher Martyn, Chris Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12637374      PMCID： PMC1125458          DOI： 10.1136/bmj.326.7389.561

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

Authors:  K P Castagnoli; S J Steyn; J P Petzer; C J Van der Schyf; N Castagnoli
Journal:  Chem Res Toxicol       Date:  2001-05       Impact factor: 3.739

2.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

3.  A retrospective study of smoking in Parkinson's disease.

Authors:  M D Nefzger; F A Quadfasel; V C Karl
Journal:  Am J Epidemiol       Date:  1968-09       Impact factor: 4.897

4.  Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

Authors:  J F Chen; K Xu; J P Petzer; R Staal; Y H Xu; M Beilstein; P K Sonsalla; K Castagnoli; N Castagnoli; M A Schwarzschild
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

5.  Dopamine-related personality traits in Parkinson's disease.

Authors:  M A Menza; L I Golbe; R A Cody; N E Forman
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

Review 6.  Nicotine and nicotinic receptors; relevance to Parkinson's disease.

Authors:  Maryka Quik; Jennifer M Kulak
Journal:  Neurotoxicology       Date:  2002-10       Impact factor: 4.294

Review 7.  The personality associated with Parkinson's disease.

Authors:  M Menza
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

8.  Cigarette smoking and the incidence of Parkinson's disease in two prospective studies.

Authors:  M A Hernán; S M Zhang; A M Rueda-deCastro; G A Colditz; F E Speizer; A Ascherio
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

Review 9.  Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

Authors:  Michael A Schwarzschild; Jiang-Fan Chen; Alberto Ascherio
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

10.  Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors.

Authors:  R Maggio; M Riva; F Vaglini; F Fornai; R Molteni; M Armogida; G Racagni; G U Corsini
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372
View more
  2 in total

1.  4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.

Authors:  Jing Hu; P A Ferchmin; Ann M Hemmerle; Kim B Seroogy; Vesna A Eterovic; Jiukuan Hao
Journal:  Front Neurosci       Date:  2017-05-29       Impact factor: 4.677

Review 2.  Nutrition and Gut-Brain Pathways Impacting the Onset of Parkinson's Disease.

Authors:  Damiano Terenzi; Anne-Katrin Muth; Soyoung Q Park
Journal:  Nutrients       Date:  2022-07-06       Impact factor: 6.706
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.